ARTICLE | Clinical News
CEA-expressing VRP vaccine: Completed Phase I/II enrollment
May 25, 2009 7:00 AM UTC
AlphaVax completed enrollment of 24 patients in an open-label, dose-escalation, U.S. Phase I/ll trial evaluating the intramuscular vaccine given every 3 weeks for a minimum of 4 immunizations, with ad...